@article{89c5867adfb64dfdb409534646203644,
title = "Normative data for the Brief Spanish-English Verbal Learning Test for representative and diverse Hispanics/Latinos: Results from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)",
abstract = "Introduction: Episodic learning and memory performance are crucial components of cognitive assessment. To meet the needs of a diverse Hispanic/Latino population, we aimed to provide normative data on the Brief Spanish-English Verbal Learning Test (B-SEVLT). Methods: The target population for the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) included individuals 45+ years old from Central American, Cuban, Dominican, Mexican, Puerto Rican, and South American backgrounds. Average age was 56.5 years ± 9.92, 54.5% were female, and mean education was 11.0 years ± 5.6 (unweighted n = 9309). Participants were administered the B-SEVLT in their preferred language (Spanish or English). Hispanic/Latino background adjusted B-SEVLT scores and percentile cut-points were created using survey-adjusted regression models. Results: Higher educational attainment, younger age, and being female were associated with higher learning and memory performance. Hispanic/Latino background groups differed in B-SEVLT performance. Discussion: Representative learning and memory norms for Hispanic/Latinos of diverse backgrounds will improve cognitive assessment and accuracy of neurocognitive disorder diagnosis.",
keywords = "Hispanic American, aging, disparities, memory, neuropsychology, sex",
author = "Jordana Breton and Stickel, {Ariana M.} and Wassim Tarraf and Gonzalez, {Kevin A.} and Keamy, {Alexandra J.} and Neil Schneiderman and Marquine, {Mar{\'i}a J.} and Zlatar, {Zvinka Z.} and Salmon, {David P.} and Melissa Lamar and Daviglus, {Martha L.} and Lipton, {Richard B.} and Gallo, {Linda C.} and Goodman, {Zachary T.} and Gonz{\'a}lez, {Hector M.}",
note = "Funding Information: The Hispanic Community Health Study/Study of Latinos was carried out as a collaborative study supported by contracts from the National Heart, Lung, and Blood Institute (NHLBI) to the University of North Carolina (N01-HC65233), University of Miami (N01-HC65234), Albert Einstein College of Medicine (N01-HC65235), Northwestern University (N01-HC65236), and San Diego State University (N01-HC65237). The following Institutes/Centers/Offices contribute to the HCHS/SOL through a transfer of funds to the NHLBI: National Institute on Minority Health and Health Disparities, National Institute on Deafness and Other Communication Disorders, National Institute of Dental and Craniofacial Research, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke, NIH Institution-Office of Dietary Supplements. Funding Information: Authors were supported by the National Institutes of Health (LCG, ML, MLD, RBL), including the National Institute on Aging (AMS, HMG, JB, WT, ZZZ) and the National Institute on Minority Health and Health Disparities (MJM). DPS receives consultancies from Biogen, Inc. and Aptinyx, Inc. HMG served as an External Advisor for the USC ADRC, UT San Antonio, and ADNI. MJM received honoraria from the California Psychological Association, payment for expert testimony from the Federal Defenders of San Diego, and financial support from the American Academy of Clinical Neuropsychology. MJM served as Chair of the Science Committee for the Hispanic Neuropsychological Society, Member of American Psychological Association Committee on Human Research. ML received support for travel from the International Neuropsychological Society (INS) and honoraria, which was often donated to the INS Early‐Stage Investigator Scholarship fund. ML served as a member of the International Advisory Board, the Latin American Brain Health Institute Santiago, Chile; Advisory Committee member for the Midwest Roybal Center for Health Promotion and Translation, University of Illinois at Chicago; Executive Advisory Board member for Air Pollution, Alzheimer's disease and related outcomes Georgetown University. RBL also receives support from the Food and Drug Administration, the S and L Marx Foundation, the Migraine Research Foundation, and the National Headache Foundation. RBL serves as a consultant, advisory board member, and received honoraria from or research support from Abbvie (Allergan), American Academy of Neurology, American Headache Society, Amgen, Biohaven, Biovision, Boston, Dr. Reddy's (Promius), Electrocore, Eli Lilly, eNeura, Equinox, GlaxoSmithKline, Grifols, Lundbeck (Alder), Merck, Pernix, Pfizer, Teva, Vector, and Vedanta. RBL held stock in Biohaven and CtrlM Health. Publisher Copyright: {\textcopyright} 2021 The Authors.",
year = "2021",
doi = "10.1002/dad2.12260",
language = "English (US)",
volume = "13",
journal = "Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring",
issn = "2352-8729",
publisher = "Elsevier BV",
number = "1",
}
